AG

Asya Grinberg

DT Dragonfly Therapeutics: 6 patents #1 of 19Top 6%
AP Acceleron Pharma: 4 patents #2 of 13Top 20%
Overall (2025): #5,369 of 469,880Top 2%
11
Patents 2025

Issued Patents 2025

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
12421295 TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof Ravindra Kumar, Dianne Sako, Roselyne Castonguay 2025-09-23
12384847 Cancer therapy involving an anti-PD1 antibody and a multi-specific binding protein that binds NKG2D, CD16, and a tumor-associated antigen Gregory P. Chang, Ann F. Cheung, Eva Gutierrez, William Haney, Nicolai Wagtmann +2 more 2025-08-12
12384851 Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of use Mitchell Bigelow, Gregory P. Chang, Ann F. Cheung, William Haney, Nicolai Wagtmann +5 more 2025-08-12
12378318 Proteins binding NKG2D, CD16 and a tumor-associated antigen Gregory P. Chang, Ann F. Cheung, Jinyan Du, Daniel Fallon, William Haney +4 more 2025-08-05
12365736 ALK7 binding proteins and uses thereof John Knopf, Ravindra Kumar, Dianne Sako, Roselyne Castonguay, Yossi Dagon +2 more 2025-07-22
12338273 Single-arm type I and type II receptor fusion proteins and uses thereof Ravindra Kumar, Dianne Sako 2025-06-24
12275791 Multi-specific binding proteins that bind HER2, NKG2D, and CD16, and methods of use Gregory P. Chang, Ann F. Cheung, Daniel Fallon, William Haney, Steven O'Neil +4 more 2025-04-15
12264200 Antibody variable domains targeting the NKG2D receptor Gregory P. Chang, Ann F. Cheung, William Haney, Bradley M. Lunde, Bianka Prinz 2025-04-01
12258380 ALK4:actriib heteromultimers and uses thereof Ravindra Kumar, Dianne Sako, Robert Scott Pearsall, Roselyne Castonguay 2025-03-25
12240887 Variant ActRIIB proteins and uses thereof Ravindra Kumar, Erik M. Vogan 2025-03-04
12215157 Multi-specific binding proteins that bind CD33, NKG2D, and CD16, and methods of use Gregory P. Chang, Ann F. Cheung, Dhruv Kam Sethi, William Haney, Bianka Prinz +4 more 2025-02-04